Renal drug transport: A review

Pharmacotherapy

Volumn 16, Issue 6 I, 1996, Pages 971-985

  Bendayan, Reina ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMILORIDE; AMPHETAMINE; ANION; ASCORBIC ACID; CATION; CIMETIDINE; DRUG CARRIER; GLYCOPROTEIN P; HEXAMETHONIUM; METFORMIN; METHADONE; METHOTREXATE; N METHYLNICOTINAMIDE; NUCLEOSIDE; OXIPURINOL; PENICILLIN G; PHENOBARBITAL; PINDOLOL; PROBENECID; PROCAINAMIDE; QUININE; RANITIDINE; SALICYLIC ACID; SULFAFURAZOLE; TRIAMTERENE; TRIMETHOPRIM; UNINDEXED DRUG; URIC ACID; ZIDOVUDINE;

AGING; BASOLATERAL MEMBRANE; BRUSH BORDER; DRUG ELIMINATION; DRUG EXCRETION; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG TRANSPORT; GENDER; GLOMERULUS FILTRATION; HUMAN; HYPOXIA; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE EXCRETION; MEMBRANE TRANSPORT; NEPHROTOXICITY; NONHUMAN; REVIEW; UREMIA; URINARY EXCRETION;

ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; HUMANS; KIDNEY; KIDNEY TUBULES; MEMBRANE PROTEINS; NUCLEOSIDE TRANSPORT PROTEINS; P-GLYCOPROTEIN; PHARMACEUTICAL PREPARATIONS;

EID: 0029846815     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (165)

1. van Ginneken CAM, Russel FGM. Saturable pharmacokinetics in the renal excretion of drugs. Clin Pharmacokinet 1989;16:38-54.
2. Peters L. Renal tubular excretion of organic bases. Pharmacol Rev 1960;12:1-35.
3. Sperber I. Secretion of organic anions in the formation of urine and bile. Pharmacol Rev 1959;11:109-34.
4. Weiner IM, Mudge GH. Renal tubular mechanisms of excretion of organic acids and bases. Am J Med 1964;36:743-62.
5. Miyamoto Y, Tiruppathi C, Ganapathy V, Leibach FH. Multiple transport systems for organic cations in renal brush border membrane vesicles. Am J Physiol 1989;256:F540-8.
6. 1 cells. J Am Soc Nephrol 1994;5:75-84.
7. Lieberman DM, Reithman RA, Ling V, Charuk JH, Goldberg H, Skorecki KL. Identification of P-glycoprotein in renal brush border membranes. Biochem Biophys Res Commun 1989;162:244-52.
8. Horio M, Chin KV, Currier SJ, et al. Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia. J Biol Chem 1989; 264:14880-4.
9. m, of the pump. Biochim Biophys Acta 1990;1027:116-22.
10. Rafi-Tari S, Bendayan R. Transport properties of 3′-azido-3′-deoxythymidine (AZT) in a cultured renal epithelium [abstr]. Clin Pharmacol Ther 1995;57:218.
11. Bendayan R, Georgis W, Rafi-Tari S. Interaction of 3′-azido-3′-deoxythymidine with the organic base transporter in a cultured renal epithelium. Pharmacotherapy 1995;15(3): 338-44.
12. Huang QQ, Yao SYH, Ritzel MUL, Paterson ARP, Cass CE, Young JD. Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. J Biol Chem 1994;269:17757-60.
13. Windhager EE. Methods for studying tubular transport of organic substances. In: Greger R, Lang F, Sibernagl S, eds. Renal transport of organic substances. Berlin: Springer-Verlag, 1981:6-16.
14. Moller JV, Sheikh MI. Renal organic anion transport system: pharmacological, physiological, and biochemical aspects. Pharmacol Rev 1983;34:315-58.
15. Rennick BR, Quebbemann AJ. Renal tubular excretion of drugs: proximal tubule secretion and metabolism. In: Fisher JW, Cafruny EJ, eds. Renal pharmacology. London: Butterworth; New York: Appleton-Centary-Crofts, 1971: 67-84.
16. Velazquez H, Wright FS. Renal micropuncture techniques. In: Windhager EE, ed. Handbook of physiology, section 8. Renal physiology. Oxford: Oxford University Press, 1992:249-69.
17. Lumsden CJ, Silverman M. Exchange of multiple indicators across the renal-like epithelia: a modeling study of six physiological regimens. Am J Physiol 1986;25:F1073-89.
18. Burg MB, Orloff J. Effect of strophantidin on electrolyte content and PAH accumulation of rabbit kidney slices. Am J Physiol 1966;202:565-71.
19. 1-methylnicotinamide uptake by brush border membrane vesicles from the dog kidney cortex. Can J Physiol Pharmacol 1990;68:467-75.
20. 1). Am J Physiol 1988;254:F351-7.
21. McKinney TD, DeLeon C, Speeg KV. Organic cation uptake by a cultured renal epithelium. J Cell Physiol 1988;137:513-20.
22. Yuan G, Ott RJ, Salgado C, Giacomini KM. Transport of organic cations by a renal epithelial cell line (OK). J Biol Chem 1991;266:8978-86.
23. Hori R, Okamura M, Takayama A, Hirozane K, Takano M. Transport of organic anion in the OK kidney epithelial cell line. Am J Physiol 1993;264:F975-80.
24. Rennick BR, Moe GK, Lyons RH, Hoobler SW, Neligh R. Absorption and renal excretion of the tetraethylammonium ion. J Pharmacol Exp Ther 1947;91:210-17.
25. 1-methylnicotinamide in the chicken. Lantbrukshögsk Ann 1948;16:49-69.
26. Young M, de Wardener HE, Miles BE. Mechanism of the renal excretion of methonium compounds. Br Med J 1951:1500-1.
27. Beckett AH, Rowland M. Urinary excretion kinetics of amphetamine in man. J Pharm Pharmacol 1965;17:628-39.
28. Beckett AH, Rowland M. Urinary excretion of methylamphetamine in man. Nature 1965;206:1260-1.
29. Aoki FY, Sitar DS. Amantadine kinetics in healthy elderly men: implications for influenza prevention. Clin Pharmacol Ther 1985;37:137-44.
30. Baselt RC, Casarett LJ. Urinary excretion of methadone in man. Clin Pharmacol Ther 1972;13:64-70.
31. 1-methylnicotinamide in the rat. Am J Physiol 1975;228: 1641-5.
32. Acara M, Roch-Ramel F, Rennick B. Bidirectional renal tubular transport of free choline: a micropuncture study. Am J Physiol 1979;236: F112-18.
33. Somogyi AA, Hovens CM, Muirhead MR, Bochner F. Renal tubular secretion of amiloride and its inhibition by cimetidine in humans and animal model. Drug Metab Dispos 1989;17:190-6.
34. Kosoglu T, Rocci ML, Vlasses PH. Trimethoprim alters the disposition of procainamide and N-acetylprocainamide. Clin Pharmacol Ther 1988;44:467-77.
35. Lassen JB, Nielsen OE. Investigations into the diuretic effect and elimination of triamterene. Acta Pharmacol Toxicol 1963;20:309-16.
36. Pruitt AW, Winkel JS, Dayton PG. Variations in the fate of triamterene. Clin Pharmacol Ther 1977;21:610-19.
37. Somogyi AA, Gugler R. Effect of variations in urine pH and flow rate on cimetidine renal disposition in man. Biopharm Drug Dispos 1985;6:345-9.
38. Beyer KN, Tillson EK, Russo HF, Paulson SF. Physiological economy of Darstine, 5-methyl-4-phenyl-1-(1-piperidyl)-3-hexanol methobromide, visceral anticholinergic agent. Am J Physiol 1953;175:39-44.
39. Bendayan R, Sullivan JT, Shaw C, Frecker RC, Sellers EM. Effect of cimetidine and ranitidine on hepatic and renal elimination of nicotine in humans. Eur J Clin Pharmacol 1990;38:165-9.
40. Somogyi AA, Bochner F, Sallustio BC. Stereoselective inhibition of pindolol renal clearance by cimetidine in humans. Clin Pharmacol Ther 1992;51:379-87.
41. Somogyi AA, McLean A, Heinzow B. Cimetidine-procainamide pharmacokinetic interaction in man. Evidence of competition for tubular secretion of basic drugs. Eur J Clin Pharmacol 1983;25:339-45.
42. Notterman DA, Drayer DE, Metakis L, Reidenberg MM. Stereoselective renal tubular secretion of quinidine and quinine. Clin Pharmacol Ther 1986;401:511-17.
43. Torretti J, Weiner IM, Mudge GH. Renal tubular secretion and reabsorption of organic bases in the dog. J Clin Invest 1962;41:793-804.
44. Rennick BR, Calhoon DM, Gandia H, Moe GK. Renal tubular secretion of tetraethylammonium in the dog and the chicken. J Pharmacol Exp Ther 1954;110:309-14.
45. Pritchard JB, Miller DS. Mechanisms mediating renal secretion of organic anions and cations. Physiol Rev 1993;73(4):765-96.
46. Roch-Ramel F, Besseghir K, Murer H. Renal excretion and tubular transport of organic anions and cations. In: Field J, ed. Handbook of physiology. Washington, DC: American Physiological Society, 1992:2189-2262.
47. Acara M, Rennick B. The biphasic effect of organic cations on the excretion of other organic cations. J Pharmacol Exp Ther 1976;199:32-40.
48. Besseghir K, Pearce LB, Rennick B. Renal tubular transport and metabolism of organic cations by the rabbit. Am J Physiol 1981;241:F308-14.
49. Rennick BR. Renal tubule transport of organic cations. Am J Physiol 1981;240F83-9.
50. Schäli C, Schild L, Overney J, Roch-Ramel F. Secretion of tetraethylammonium by proximal tubules of rabbit kidneys. Am J Physiol 1983;245:F238-46.
51. Kinsella JL, Holohan PD, Pessah NI, Ross CR. Transport of organic ions in renal cortical luminal and antiluminal membrane vesicles. J Pharmacol Exp Ther 1979;209:443-50.
52. Takano M, Inui KI, Okano T, Saito H, Hori R. Carrier-mediated transport systems of tetraethylammonium in rat renal brush-border and basolateral membrane vesicles. Biochim Biophys Acta 1984;773:113-24.
53. Montrose-Rafizadeh C, Mingard F, Murer H, Roch-Ramel F. Carrier-mediated transport of tetraethylammonium across rabbit renal basolateral membrane. Am J Physiol 1989;257:F243-51.
54. Escobar M, Wong LTY, Sitar DS. Bicarbonate-dependent amantadine transport by rat renal cortical proximal and distal tubules. J Pharmacol Exp Ther 1994;270:979-86.
55. Berndt WO. Organic base transport: a comparative study. Pharmacology 1981;22:251-62.
56. Van Dyke RW. Acid transport by intracellular vesicles. J Intern Med 1990;228:41-6.
57. Holohan PD, Ross CR. Mechanisms of organic cation transport in kidney plasma membrane vesicles. 2. pH studies. J Pharmacol Exp Ther 1981;216:294-8.
58. Sokol PP, Holohan PD, Ross CR. Electroneutral transport of organic cations in canine renal brush border membrane vesicles. J Pharmacol Exp Ther 1985;233:694-9.
59. 1-methylnicotinamide across brush border membrane vesicles from rabbit kidney. Am J Physiol 1985;249:F903-11.
60. McKinney TD, Kunnemann ME. Procainamide transport in rabbit renal cortical brush border membrane vesicles. Am J Physiol 1985;249:F532-41.
61. Hsyu PH, Giacomini KM. The pH gradient-dependent transport of organic cations in the renal brush border membrane studies with acridine orange. J Biol Chem 1987;262:3964-8.
62. 1-dicyclohexyl-carbodiimide, N-ethylmaleimide and bafilomycin. Kidney Int 1991;40:564-70.
63. Pitts R. Physiology of the kidney and body fluid. Chicago: Year Book, 1965:116-30.
64. Weiner IM. Urate transport in the nephron. Am J Physiol 1979;237:F85-92.
65. Weiner IM, Washington JA II, Mudge GH. On the mechanism of action of probenecid on renal tubular secretion. Bull Johns Hopkins Hosp 1960;106:333-46.
66. Gutman AB, Yü TF, Sirota JH. A study by simultaneous clearance techniques of salicylate excretion in man. Effect of alkalinization of the urine by bicarbonate administration; effect of probenecid. J Clin Invest 1955;34:711-21.
67. Waddell WJ, Butler TC. The distribution and excretion of phenobarbital. J Clin Invest 1957;36:1217-26.
68. Elion GB, Yü TF, Hitchings GH. Renal clearance of oxipurinol, the chief metabolite of allopurinol. Am J Med 1968;45:69-77.
69. Arita T, Hori R, Owada E, Takahashi K. Transformation and excretion of drugs in biological systems. I. Renal excretion mechanisms of sulfonamides. Chem Pharm Bull 1969;17: 2526-32.
70. Liegler DG, Henderson ES, Hahn MA, Oliverio VT. The effect of organic acids on renal clearance of methotrexate in man. Clin Pharmacol Ther 1969;10:849-57.
71. Bergeron MG, Gennari FJ, Barza M, Weinstein L, Cortell S. Renal tubular transport of penicillin G and carbenicillin in the rat. J Infect Dis 1975;132:374-83.
72. Friedman GJ, Sherry S, Ralli EP. The mechanism of the excretion of vitamin C by the human kidney at low and normal plasma levels of ascorbic acid. J Clin Invest 1940;19:685-9.
73. Grantham JJ, Qualizza PB, Irwin RL. Net fluid secretion in proximal straight renal tubules in vitro: role of PAH. Am J Physiol 1974;226:191-7.
74. Podevin RA, Boumendil-Podevin EF. Monovalent cation and ouabain effects on PAH uptake by rabbit kidney slices. Am J Physiol 1977;232:F239-47.
75. Podevin RA, Boumendil-Podevin EF, Priol C. Concentrative PAH transport by rabbit kidney slices in the absence of metabolic energy. Am J Physiol 1977;235:F278-85.
76. Sheikh MI, Maxild J, Moller JV. Effect of vanadate on the renal accumulation of p-aminohippurate in the rabbit kidney tubules in vitro. Biochem Pharmacol 1981;30:2141-6.
77. Shimomura A, Chonko AM, Grantham JJ. Basis for heterogeneity of para-aminohippurate secretion in rabbit proximal tubules. Am J Physiol 1981;240:F430-6.
78. + of p-aminohippuric acid uptake into rat renal basolateral membrane vesicles. Am J Physiol 1987;253:F795-801.
79. Pritchard JB. Coupled transport of p-aminohippurate by rat basolateral membrane vesicles. Am J Physiol 1988;255: F597-604.
80. Pritchard JB. Rat renal cortical slices demonstrate p-aminohippurate/glutarate exchange and sodium/glutarate coupled p-aminohippurate transport. J Pharmacol Exp Ther 1990;255:969-75.
81. Eveloff J, Morishige WK, Hong SK. The binding of phenol red to rabbit renal cortex. Biochim Biophys Acta 1976;448:167-80.
82. Sheikh MI. Renal handling of phenol red. I. A comparative study on the accumulation of phenol red and p-aminohippurate in rabbit kidney tubules in vitro. J Physiol 1972;227:565-90.
83. Miller DS, Stewart DE, Pritchard JB. Intracellular compartmentation of organic anions within renal cells. Am J Physiol 1993;264:R882-90.
84. Berner W, Kinne R. Transport of p-aminohippuric acid by plasma membrane vesicles isolated from rat kidney cortex. Pflugers Arch 1976;361:269-77.
85. Blomstedt JW, Aronson PS. pH gradient stimulated transport of urate and p-aminohippurate in dog renal microvilli membrane vesicles. J Clin Invest 1980;65:931-4.
86. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987;84:265-9.
87. Thiebault F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 1987;84:7735-8.
88. Willingham MC, Richert ND, Cornwall MM, et al. Immunocytochemical localization of P170 at the plasma membrane of multidrug resistant human cells. J Histochem Cytochem 1987;35:1451-6.
89. Gerlach JH, Kartner N, Bell D. Multidrug resistance. Cancer Surv 1986;5:25-46.
90. Chen CJ, Chin JE, Veda K. Internal duplication and homology with bacterial transport proteins in the MDR1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 1986;47:381-9.
91. Gros P, Neriah YP, Groop JM. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 1986;323:728-31.
92. Ichikawa M, Yashimura A, Sumizawa T, et al. Interaction of organic chemicals with P-glycoprotein to the adrenal gland, kidney and a multidrug-resistant KB cell. J Biol Chem 1991;266(2):903-8.
93. 1). J Pharmacol Exp Ther 1992;263:840-5.
94. de Lannoy IAM, Silverman M. The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin. Biochem Biophys Res Commun 1992;189:551-7.
95. Ito S, Woodland C, Harper PA, Koren G. P-Glycoprotein-mediated renal tubular secretion of digoxin: the toxicological significance of the urine-blood barrier model. Life Sci 1993;53(2):25-31.
96. Kerr DJ, Graham J, Cummings J, et al. The effect of verapamil on the pharmacokinetics of Adriamycin. Cancer Chemother Pharmacol 1986;18:239-42.
97. Lum BL, Kaubisch S, Yahanda AM, et al. Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporin in a phase I trial to modulate multidrug resistance. J Clin Oncol 1992;28:238-41.
98. Plagemann PGW, Wohlhueter RM. Permeation of nucleosides, nucleic acid bases and nucleotides. In: Bronner F, Kleinzeller A, eds. Current topics in membranes and transport. New York: Academic Press, 1980:225-329.
99. + dependent uridine transport in rat renal brush border membrane vesicles. Biochim Biophys Acta 1988;942:139-49.
100. Vijayalakshmi D, Belt JA. Sodium-dependent nucleoside transport in mouse intestinal epithelial cells. Biol Chem 1988;263:19419-23.
101. Jarvis SM. Characterization of sodium dependent nucleoside transport in rabbit intestinal brush border membrane vesicles. Biochim Biophys Acta 1989;979:132-8.
102. Jarvis SM, Young JD. Nucleoside transport in rat erythrocytes: two components with differences in sensitivity to inhibition by nitrobenzylthioinosine and P-chloromercuriphenyl sulfonate. J Membr Biol 1986;93(1):1-10.
103. Gutierrez MM, Brett CM, Ott RJ. Nucleoside transport in brush border membrane vesicles from human kidney. Biochim Biophys Acta 1992;1105:1-9.
104. Brett CM, Washington CB, Ott RJ, Gutierrez M, Giacomini KM. Interaction of nucleoside analogues with the sodium nucleoside transport system in brush border membrane vesicles from human kidney. Pharm Res 1993;10:423-6.
105. Tune BM, Wu KY, Kempson RL. Inhibition of transport and prevention of toxicity of cephaloridine in the kidney. Dose responsiveness of the rabbit and guinea pig to probenecid. J Pharmacol Exp Ther 1977;202:466-71.
106. Elbourne I, Lumbers ER, Hill KJ. The secretion of organic acids and bases by the ovine fetal kidney. Exp Physiol 1990;75:211-21.
107. Hook JB, Bailie MD. Perinatal renal pharmacology. Annu Rev Pharmacol Toxicol 1979;19:491-509.
108. Hook JB, Hewitt WR. Development of mechanisms for drug excretion. Am J Med 1977;62:497-506.
109. Bowman HM, Hook JB. Sex differences in organic ion transport by the rat kidney. Proc Soc Exp Biol Med 1972;141:258-62.
110. Wong LTY, Escobar MR, Smyth DD, Sitar DS. Gender-associated differences in rat renal tubular amantadine transport and absence of stereoselective transport inhibitions by quinine and quinidine in distal tubules. J Pharmacol Exp Ther 1993;267:1440-4.
111. Sitar DS, Wong LTY, Aoki FY. Gender-associated difference in renal amantadine excretion in chronic smokers and non-smokers. Clin Pharmacol Ther 1993;53:239.
112. 14-acetyl metabolite by the isolated perfused rat kidney. Drug Metab Dispos 1984;12:607-13.
113. Depner TA. Suppression of tubular anion transport by an inhibitor of serum protein binding in uremia. Kidney Int 1981;20:511-18.
114. Depner TA, Gulyassy PF. Plasma protein binding in uremia: extraction and characterization of an inhibitor. Kidney Int 1980;18:86-94.
115. Depner TA, Sanaka T, Stanfel LA. Suppression of para-aminohippurate transport in the isolated perfused kidney by an inhibitor of protein binding in uremia. Am J Kidney Dis 1984;3:280-6.
116. 1-methylnicotinamide in rats. J Pharmacobiodyn 1985;8:20-4.
117. Diamond GL, Quebbemann AJ. In vivo quantification of renal sulfate and glucuronide conjugation in the chicken. Drug Metab Dispos 1981;9:402-9.
118. 3H] morphine in isolated, nonperfused proximal tubular segments of the rabbit kidney. J Pharmacol Exp Ther 1982;223:811-15.
119. Bendayan R. Development of an hypoxia tissue cell culture system for the study of renal drug transport [abstr]. Clin Pharmacol Ther 1995;57:222.
120. Kosoglu T, Vlasses PH. Drug interactions involving renal transport mechanisms: an overview. Drug Intell Clin Pharm 1989;23:116-21.
121. Lai M, Jiang FM, Chung CH, Chen HC, Chao PDL. Dose dependent effect of cimetidine on procainamide disposition in man. Int J Clin Pharmacol Ther Toxicol 1988;26:118-21.
122. Muirhead MR, Somogyi AA, Rolan PE, Bochner FB. Effect of cimetidine on renal and hepatic drug elimination studies with triamterene. Clin Pharmacol Ther 1986;40:400-7.
123. van Crugten JV, Bochner F, Keal J, Somogyi A. Selectivity of the cimetidine-induced alterations in the renal handling of organic substrates in humans studies with anionic, cationic and zwitterionic drugs. J Pharmacol Exp Ther 1986;236: 481-7.
124. Somogyi AA, Stockley C, Keal J, Rolan P, Bochner F. Reduction of metformin renal tubular secretion by cimetidine in man. Br J Clin Pharmacol 1987;23:545-51.
125. Chatton JY, Munafo A, Chave JP, et al. Trimethoprim, alone or in combination with sulphamethoxazole, decreases the renal excretion of zidovudine and its glucuronide. Br J Clin Pharmacol 1992;34:551-4.
126. Fletcher CV, Henry WK, Noormohamed SE, Rhame FS, Balfour HH. The effect of cimetidine and ranitidine administration with zidovudine. Pharmacotherapy 1995;15(6):701-8.
127. Hsyu PH, Giacomini KM. Stereoselective renal clearance of pindolol in humans. J Clin Invest 1985;76:1720-6.
128. Mikus G, Eichelbaum M, Fisher C, Gumulka S, Klotz U, Kroemer HK. Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug action. J Pharmacol Exp Ther 1990;253:1042-8.
129. McKinney TD, Myers P, Speeg KV. Cimetidine secretion by rabbit renal tubules in vitro. Am J Physiol 1981;241:F69-76.
130. Cacini W, Keller MB, Grand VR. Accumulation of cimetidine by kidney cortex slices. J Pharmacol Exp Ther 1982;221:342-6.
131. Hsyu PH, Gisclon LG, Hui AG, Giacomini KM. Interactions of organic anions with the organic cation transporter in renal BBMV. Am J Physiol 1988;254:F56-61.
132. Brāndie E, Greven J. Transport of cimetidine across the basolateral membrane of rabbit kidney proximal tubules: interactions with organic anions. Pharmacology 1992;45: 231-40.
133. Ott RJ, Hui AC, Giacomini KM. Mechanisms of interactions between organic anions and the organic cation transporter in renal brush border membrane vesicles. Biochem Pharmacol 1990;40:659-61.
134. Gisclon LG, Boyd RA, Giacomini KM. Probenecid inhibits cimetidine renal elimination. Clin Pharmacol Ther 1989;45:444-52.
135. Arendshorst WJ, Selkhurt E. Renal tubular mechanisms for creatinine secretion in the guinea pig. Am J Physiol 1970;218:1661.
136. Burry HC, Dieppe PA. Apparent reduction of endogenous creatinine clearance by salicylate. Br Med J 1976;2:16-17.
137. Berglund F, Killander J, Pompeius R. Effect of trimethoprim-sulfamethoxazole on the renal excretion of creatinine in man. J Urol 1975;114:802.
138. Burgess E, Blair A, Krichman K, Culter RE. Inhibition of renal creatinine secretion by cimetidine in humans. Renal Physiol 1982;5:27.
139. Dubb JW, Stole RM, Familiar RG, Lee K, Alexander F. Effect of cimetidine on renal function in normal man. Clin Pharmacol Ther 1978;24:76-83.
140. Oprovil M, Keusch G, Luthy R. Pyrimethamine inhibits renal secretion of creatinine. Antimicrob Agents Chemother 1993;37:1056-60.
141. Roubenoff R, Drew H, Moyer M, Petri M, Whiting-O'Keefe O, Hellmann DB. Oral cimetidine improves the accuracy and precision of creatinine clearance in lupus nephritis. Ann Intern Med 1990;113:501-6.
142. Hilbrands LB, Artz MA, Wetzels JFM, Koene RAP. Cimetidine improves the reliability of creatinine as a marker of glomerular filtration. Kidney Int 1991;40:1171-6.
143. Kampmann J, Molholm-Hansen J, Siersbaeck-Nielsen K, Laursen H. Effect of some drugs on penicillin half-life in blood. Clin Pharmacol Ther 1972;13:516-19.
144. DeMiranda P, Good SS, Yarchoan R, et al. Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex. Clin Pharmacol Ther 1989;46:494-500.
145. Hedaya A, Elmquist F, Sawchuk J. Probenecid inhibits the metabolic and renal clearance of zidovudine (AZT) in human volunteers. Pharm Res 1990;7:411-17.
146. Mays DC, Dixon KF, Balboa A, et al. A nonprimate animal model applicable to zidovudine pharmacokinetics in humans. Inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats. J Pharmacol Exp Ther 1991;259:1261-70.
147. Quian M, Finco TS, Mehta M, Viswanathan CT, Gallo JM. Pharmacokinetic evaluation of drug interactions with zidovudine in monkeys. 1. Probenecid and zidovudine. J Pharm Sci 1991;80:1007-11.
148. Wong SL, Hedaya MA, Sawchuk RJ. Competitive inhibition of zidovudine clearance by probenecid during continuous coadministration. Pharm Res 1992;9:228-35.
149. Odlind B, Beermann B. Renal tubular secretion and effects of furosemide. Clin Pharmacol Ther 1980;27:784-90.
150. Noormohamed FH, McNabb RW, Dixey JJ, Lant AF. Renal responses and pharmacokinetics of pirenatide in humans: effect of route of administration, state of hydration and probenecid pretreatment. J Pharmacol Exp Ther 1990; 254:992-9.
151. Noormohamed FH, McNabb RW, Lant AF. Pharmacokinetic and pharmacodynamic actions of enalapril in humans: effect of probenecid pretreatment. J Pharmacol Exp Ther 1990;253:362-8.
152. Brown GR. Cephalosporin-probenecid drug interactions. Clin Pharmacokinet 1993;24(4):289-300.
153. Jaehde U, Sörgel F, Reiter A, Sigl G, Naber KG, Shunack W. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans. Clin Pharmacol Ther 1995;58: 532-41.
154. Schacht J. Isolation of an aminoglycoside receptor from guinea pig inner ear tissues and kidney. Arch Otorhinolaryngol 1979;224:129-34.
155. Sastrasinh M, Knauss TC, Weinberg JM, Humes HD. Identification of the aminoglycoside binding site in rat renal brush border membranes. J Pharmacol Exp Ther 1982;222: 350-8.
156. Walker RJ, Duggin GG. Drug nephrotoxicity. Annu Rev Pharmacol Toxicol 1988;28:331-45.
157. Lipsky JJ, Cheng L, Sacktor B, Lietman PS. Gentamicin uptake by renal tubule brush border membrane vesicles. J Pharmacol Exp Ther 1980;215:390-3.
158. Josepovitz C, Pastoriza-Munoz E, Timmerman D, et al. Inhibition of gentamicin uptake in rat renal cortex in vivo by aminoglycosides and organic polycations. J Pharmacol Exp Ther 1982;223:314-21.
159. +-adenosine triphosphatase by gentamicin. J Pharmacol Exp Ther 1984;231:248-53.
160. Sokol PP, Huialt KR, Holohan PD, Ross CR. Gentamicin and verapamil compete for a common transport mechanism in renal brush border membrane vesicle. J Pharmacol Exp Ther 1989;251:937-42.
161. 1 lysosomes and alter cell function. Am J Physiol 1994;266:C52-7.
162. 1 [abstr]. Clin Pharmacol Ther 1996;59:156.
163. Tilstone WJ, Semple PF, Lawson DH, Boyle JA. Effects of furosemide on glomerular filtration rate and clearance of practolol, digoxin, cephaloridine and gentamicin. Clin Pharmacol Ther 1977;22:389-94.
164. Tune B, Fernholt M, Schwartz A. Mechanism of cephaloridine transport in the kidney. J Pharmacol Exp Ther 1974;191:311-17.
165. Tune BM. Effect of organic acid transport inhibitors on renal cortical uptake and proximal tubular toxicity of cephaloridine. J Pharmacol Exp Ther 1972;181:250-6.